|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
5R01CA148966-05
|
$693,999
|
$693,999
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$3,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$5,940
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$143,410
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$7,157
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
1R01CA184820-01
|
$399,474
|
$399,474
|
DUBOIS, RAYMOND
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$6,482
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
|
5K23CA160664-02
|
$142,986
|
$142,986
|
GODOY, GUILHERME
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
1P50CA186784-01
|
$2,162,000
|
$129,720
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
1U01CA187956-01
|
$595,990
|
$595,990
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$6,912
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-05
|
$339,713
|
$84,928
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
5R01CA170549-03
|
$490,642
|
$490,642
|
PANIGRAHY, DIPAK
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Feasibility of grape seed extract for lung cancer chemoprevention
|
5R21CA173211-02
|
$26,283
|
$26,283
|
MAO, JENNY
|
BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$8,814
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers
|
5R01CA156186-05
|
$522,335
|
$130,584
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-23
|
$1,780,348
|
$1,780,348
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as targets for cancer prevention
|
5R01CA080946-14
|
$305,316
|
$305,316
|
GLADYSHEV, VADIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-06
|
$1,849,394
|
$1,849,394
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Effects of Vitamin D on Mammographic Density and Breast Tissue
|
1R01CA178263-01A1
|
$379,851
|
$379,851
|
REXRODE, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-15
|
$4,715,223
|
$330,066
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
5U54CA163060-04
|
$1,424,703
|
$85,482
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S1
|
$74,051
|
$4,443
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S2
|
$29,166
|
$1,750
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S3
|
$145,188
|
$8,711
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
5K12CA076917-17
|
$631,819
|
$63,182
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-24
|
$4,748,649
|
$284,919
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular Mechanisms of Prostate Cancer Chemoprevention by Apigenin
|
5R01CA108512-10
|
$231,636
|
$231,636
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
|
5R01CA168586-02
|
$319,021
|
$319,021
|
LETTERIO, JOHN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplas
|
1U01CA181770-01
|
$561,786
|
$561,786
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
5P50CA150964-04
|
$2,162,001
|
$194,580
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
|
5R01CA157735-04
|
$306,426
|
$306,426
|
TOCHTROP, GREGORY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention
|
5R01CA142879-05
|
$313,356
|
$313,356
|
EPSTEIN, ERVIN
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
S1P Lyase in colon cancer
|
5R01CA129438-07
|
$304,668
|
$76,167
|
SABA, JULIE
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
|
5R01CA172896-02
|
$328,604
|
$328,604
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
3U10CA045418-27S1
|
$237,321
|
$18,986
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
|
5R01CA140245-05
|
$519,121
|
$519,121
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S1
|
$121,881
|
$3,656
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S2
|
$64,080
|
$1,922
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S3
|
$126,241
|
$3,787
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S4
|
$12,600
|
$378
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-31
|
$2,119,061
|
$63,572
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Increasing breast cancer chemoprevention in the primary care setting
|
1R01CA177995-01A1
|
$658,722
|
$658,722
|
CREW, KATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
2P30CA013696-40
|
$3,596,904
|
$71,938
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S1
|
$125,000
|
$2,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S2
|
$50,000
|
$1,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S3
|
$320,000
|
$6,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S4
|
$75,000
|
$1,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbia University Medical Center Minority-Based Community Clinical Oncology Pro
|
3U10CA167791-02S1
|
$73,416
|
$5,873
|
KELLY, KARA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbus Community Clinical Oncology Program (Columbus CCOP)
|
3U10CA035261-30S1
|
$135,525
|
$10,842
|
KUEBLER, PHILIP
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
Total relevant funding to Chemoprevention for this search: $108,326,376
|